Reports are emerging about the performance of branded pharmaceuticals stocks, with some outlets focusing on the first quarter and others on the fourth quarter. Various companies, including Supernus Pharmaceuticals, Merck, Zoetis, Eli Lilly, Royalty Pharma, Elanco, and Pfizer, are being benchmarked against their peers. The specific details and comparisons of their performances are not consistent across the reports, suggesting some uncertainty about the relative standings of these companies.